AXEVIL Capital

ElevenLabs Stock

Private company — ElevenLabs is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.

Status source: AXEVIL investment team

$88.69 per share (AXEVIL consensus estimate)

Source: AXEVIL consensus of recent secondary transactions · as of 11 August 2026

Valuation: $18.01B

Source: D, February 2026 — post-money $11B

Data last updated: 11 August 2026

About ElevenLabs

British developer of AI voice synthesis and cloning, voiceover, and dubbing technology. Raised $500M in a Series D in February 2026 led by Sequoia at an $11B valuation, more than triple its January 2025 level. Annual recurring revenue reached about $500M. Exploring an IPO.

  • Sector: Artificial Intelligence
  • Headquarters: London, United Kingdom
  • Founded: 2022

Funding rounds

DateRoundPrice / sharePost-money valuation
4 February 2026D$54.18$11B
30 January 2025C$17.47$3.3B
22 January 2024B$6.36$1.09B
1 May 2023A-1$0.64$120M
23 January 2023A-4$0.08$10M

Latest news

Frequently asked questions

Can I buy ElevenLabs stock?

Not on a public exchange — ElevenLabs is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.

How much is one ElevenLabs share?

A private company has no single official price. AXEVIL's consensus estimate is $88.69 per share as of 11 August 2026. Its most recent round implied a post-money valuation of $11B (February 2026).

When will ElevenLabs IPO?

No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.

Is ElevenLabs publicly traded?

No. ElevenLabs is a private company and its shares are not listed on any public exchange.

Similar companies

Risk disclosure

Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.

Full legal disclosures · All companies